Skip to content

Part of the World CNS Series: Neurodegenerative Drug Development Summit | Neuroimmunology Drug Development Summit | Neuromuscular Drug Development Summit  | Neuropsychiatry Drug Development Summit | Blood-Brain Barrier Summit | Biomarkers for Alzheimer’s Disease Summit

Untitled design (9)

Returning In 2022

 Register Interest

  • Home
  • About
    • About Event
    • Content Library
  • What’s On?
    • Full Event Guide
    • Speakers
    • Conference Agenda
      • Day One
      • Day Two
  • Partner
    • Partnership Opportunities
    • 2021 Partners
    • Media Partners
  • Take Part
    • Register
    • Contact us
Take Part › Register

Register

Register Interest for the Neuropsychiatric Drug Development Summit

Gain an important market update on the progress of neuropsychiatric drug development through pioneering clinical case studies across schizophrenia, SUD and treatment resistant depression
Engage in critical discussions with industry experts and hear insights into novel electrophysiological biomarkers of synaptic plasticity in humans and how we can establish digital therapeutics as a meaningful new treatment category for patients
Establish lasting connections with this dedicated community to accelerate your products to market and help patients in need
REGISTER INTEREST

OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com

ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers.

LOCATION

Virtual Event

SEARCH

ORGANISED BY

HansonWade Logo

Terms & Conditions

Privacy Policy

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.